Anne‐Marie Lamhonwah

Novel<i>OCTN2</i>mutations: No genotype–phenotype correlations: Early carnitine therapy prevents cardiomyopathy

Anne‐Marie Lamhonwah, S. E. Olpin, R. J. Pollitt et al. · American Journal of Medical Genetics · 2002 · 119 citations

Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise

Anne‐Marie Lamhonwah, Christine E. Bear, Ling Jun Huan et al. · Annals of Neurology · 2010 · 108 citations

Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria

Anne‐Marie Lamhonwah, Ingrid Tein · Biochemical and Biophysical Research Communications · 2006 · 102 citations

Mammalian Mitochondria, Organic Cation/carnitine Transporter, Mitochondrial Function +9

A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn’s disease locus (IBD5)

Anne‐Marie Lamhonwah, Jennifer Skaug, Stephen W. Scherer et al. · Biochemical and Biophysical Research Communications · 2003 · 70 citations

Disease Locus, Biochemistry, Crohn ’ +8

OCTN3 is a mammalian peroxisomal membrane carnitine transporter

Anne‐Marie Lamhonwah, Cameron Ackerley, A Tilups et al. · Biochemical and Biophysical Research Communications · 2005 · 64 citations

Biochemistry, Natural Sciences, Membrane Transport +5